Detalhe da pesquisa
1.
Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo.
Drug Metab Dispos
; 51(7): 851-861, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055191
2.
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.
Pharm Res
; 40(11): 2567-2584, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523014
3.
Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition.
Drug Metab Dispos
; 49(12): 1063-1069, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599018
4.
Enhanced and Persistent Inhibition of Organic Cation Transporter 1 Activity by Preincubation of Cyclosporine A.
Drug Metab Dispos
; 47(11): 1352-1360, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427432
5.
Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
Mol Pharm
; 16(6): 2342-2353, 2019 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039308
6.
Role of dietary fiber in the recovery of the human gut microbiome and its metabolome.
Cell Host Microbe
; 29(3): 394-407.e5, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33440171